AP303

· Alebund Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for AP303, covering 2024-05-30 to 2025-09-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in DKD Patients [Phase 1]